Vosaroxin

DB11999InvestigationalSmall molecule

Vosaroxin is under investigation for the treatment of Leukemia, Myeloid, Acute.

Chemical structure of Vosaroxin
Mechanism
Curator reviewed
Formula / weight
C18H19N5O4S · 401.44 g/mol (avg)
Also known as
Voreloxin
Code names
AG-7352 · SNS-595 · SPC-595

Resolves to

Compound
UNIIK6A90IIZ19CAS175414-77-4ChEMBLCHEMBL68117PubChem9952884
Clinical / RWD
ATCL01XX53
Structure
InChIKeyXZAFZXJXZHRNAQ-STQMWFEESA-NSMILESCN[C@H]1CN(C[C@@H]1OC)C1=CC=C2C(=O)C(=CN(C3=NC=CS3)C2=N1)C(O)=O
Targets
Q02880TOP2BP11388TOP2A

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 4 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vosaroxin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In